Q.T. Ostrom, H. Gittleman, J. Xu, C. Kromer, Y. Wolinsky, C. Kruchko, J.S. Barnholtz-Sloan, CBTRUS Statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2009–2013. Neuro-Oncol 18(suppl_5), v1-v75 (2016). https://doi.org/10.1093/neuonc/now207
D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee, P.C. Burger, A. Jouvet, B.W. Scheithauer, P. Kleihues, The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114(2), 97–109 (2007). https://doi.org/10.1007/s00401-007-0243-4
PubMed PubMed Central Google Scholar
P.Y. Wen, S. Kesari, Malignant gliomas in adults. N. Engl. J. Med. 359(5), 492–507 (2008). https://doi.org/10.1056/NEJMra0708126
F.B. Furnari, T. Fenton, R.M. Bachoo, A. Mukasa, J.M. Stommel, A. Stegh, W.C. Hahn, K.L. Ligon, D.N. Louis, C. Brennan, L. Chin, R.A. DePinho, W.K. Cavenee, Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 21(21), 2683–2710 (2007). https://doi.org/10.1101/gad.1596707
D.N. Louis, A. Perry, G. Reifenberger, A. von Deimling, D. Figarella-Branger, W.K. Cavenee, H. Ohgaki, O.D. Wiestler, P. Kleihues, D.W. Ellison, The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 131(6), 803–820 (2016). https://doi.org/10.1007/s00401-016-1545-1
G. Alzial, O. Renoult, F. Paris, C. Gratas, A. Clavreul, C. Pecqueur, Wild-type isocitrate dehydrogenase under the spotlight in glioblastoma. Oncogene 41(5), 613–621 (2022). https://doi.org/10.1038/s41388-021-02056-1
A.M. Molinaro, J.W. Taylor, J.K. Wiencke, M.R. Wrensch, Genetic and molecular epidemiology of adult diffuse glioma. Nat. Rev. Neurol. 15(7), 405–417 (2019). https://doi.org/10.1038/s41582-019-0220-2
PubMed PubMed Central Google Scholar
D.R. Welch, P.S. Steeg, C.W. Rinker-Schaeffer, Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis. Breast Cancer Res.: BCR 2(6), 408–416 (2000)
CAS PubMed PubMed Central Google Scholar
R.S. Samant, M.J. Seraj, M.M. Saunders, T.S. Sakamaki, L.A. Shevde, J.F. Harms, T.O. Leonard, S.F. Goldberg, L. Budgeon, W.J. Meehan, C.R. Winter, N.D. Christensen, M.F. Verderame, H.J. Donahue, D.R. Welch, Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clin. Exp. Metastasis 18(8), 683–693 (2000)
P.R. Bucciarelli, K.S. Tan, N.P. Chudgar, W. Brandt, J. Montecalvo, T. Eguchi, Y. Liu, R. Aly, W.D. Travis, P.S. Adusumilli, D.R. Jones, BRMS1 expression in surgically resected lung adenocarcinoma predicts future metastases and is associated with a poor prognosis. J. Thorac. Oncol. 13(1), 73–84 (2018). https://doi.org/10.1016/j.jtho.2017.10.006
M.A. Kodura, S. Souchelnytskyi, Breast carcinoma metastasis suppressor gene 1 (BRMS1): update on its role as the suppressor of cancer metastases. Cancer Metastasis Rev. 34(4), 611–618 (2015). https://doi.org/10.1007/s10555-015-9583-z
Z. Yang, F. Liu, Z.L. Yang, BRMS1 and HPA as progression, clinical biological behaviors, and poor prognosis-related biomarkers for gallbladder adenocarcinoma. Appl. Immunohistochem. Mol. Morphol.: AIMM 24(4), 275–282 (2016). https://doi.org/10.1097/PAI.0000000000000183
S. Zhang, Q.D. Lin, W. Di, Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1. Int. J. Gynecol. Cancer: Off. J. Int. Gynecol. Cancer Soc. 16(2), 522–531 (2006). https://doi.org/10.1111/j.1525-1438.2006.00547.x
Y. Zhang, J. Guan, Y. Sun, J. Chai, T. Zou, W. Gong, Z. Zhu, X. Liu, Q. Hou, X. Song, Effect of BRMS1 on tumorigenicity and metastasis of human rectal cancer. Cell Biochem. Biophys. 70(1), 505–509 (2014). https://doi.org/10.1007/s12013-014-9948-x
D.R. Welch, C.A. Manton, D.R. Hurst, Breast Cancer Metastasis Suppressor 1 (BRMS1): robust biological and pathological data, but still enigmatic mechanism of action. Adv. Cancer Res. 132, 111–137 (2016). https://doi.org/10.1016/bs.acr.2016.05.003
P. Mei, J. Bai, M. Shi, Q. Liu, Z. Li, Y. Fan, J. Zheng, BRMS1 suppresses glioma progression by regulating invasion, migration and adhesion of glioma cells. PLoS ONE 9(5), e98544 (2014). https://doi.org/10.1371/journal.pone.0098544
CAS PubMed PubMed Central Google Scholar
A.J. Levine, J. Momand, C.A. Finlay, The p53 tumour suppressor gene. Nature 351(6326), 453–456 (1991). https://doi.org/10.1038/351453a0
K. Watanabe, K. Sato, W. Biernat, O. Tachibana, K. von Ammon, N. Ogata, Y. Yonekawa, P. Kleihues, H. Ohgaki, Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin. Cancer Res. 3(4), 523–530 (1997)
C. Sarkar, A.M. Ralte, M.C. Sharma, V.S. Mehta, Recurrent astrocytic tumours–a study of p53 immunoreactivity and malignant progression. Br. J. Neurosurg. 16(4), 335–342 (2002)
P.A. Muller, K.H. Vousden, p53 mutations in cancer. Nat. Cell Biol. 15(1), 2–8 (2013). https://doi.org/10.1038/ncb2641
M. Cicek, R. Fukuyama, D.R. Welch, N. Sizemore, G. Casey, Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity. Cancer Res. 65(9), 3586–3595 (2005). https://doi.org/10.1158/0008-5472.CAN-04-3139
Y. Wu, W. Jiang, Y. Wang, J. Wu, H. Saiyin, X. Qiao, X. Mei, B. Guo, X. Fang, L. Zhang, H. Lou, C. Wu, S. Qiao, Breast cancer metastasis suppressor 1 regulates hepatocellular carcinoma cell apoptosis via suppressing osteopontin expression. PLoS ONE 7(8), e42976 (2012). https://doi.org/10.1371/journal.pone.0042976
CAS PubMed PubMed Central Google Scholar
J. Yang, B. Zhang, Y. Lin, Y. Yang, X. Liu, F. Lu, Breast cancer metastasis suppressor 1 inhibits SDF-1alpha-induced migration of non-small cell lung cancer by decreasing CXCR4 expression. Cancer Lett. 269(1), 46–56 (2008). https://doi.org/10.1016/j.canlet.2008.04.016
I. Morimoto, Y. Sasaki, S. Ishida, K. Imai, T. Tokino, Identification of the osteopontin gene as a direct target of TP53. Genes Chromosomes Cancer 33(3), 270–278 (2002). https://doi.org/10.1002/gcc.10020
M. Eren, A.E. Boe, E.A. Klyachko, D.E. Vaughan, Role of plasminogen activator inhibitor-1 in senescence and aging. Semin Thromb. Hemost. 40(6), 645–651 (2014). https://doi.org/10.1055/s-0034-1387883
CAS PubMed PubMed Central Google Scholar
S.A. Mehta, K.W. Christopherson, P. Bhat-Nakshatri, R.J. Goulet Jr., H.E. Broxmeyer, L. Kopelovich, H. Nakshatri, Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion. Oncogene 26(23), 3329–3337 (2007). https://doi.org/10.1038/sj.onc.1210120
E.H. Hall, Y. Liu, A. Xiao, L. Shock, D.L. Brautigan, M.W. Mayo, P.S. Adusumilli, D.R. Jones, Inhibition of breast cancer metastasis suppressor 1 promotes a mesenchymal phenotype in lung epithelial cells that express oncogenic K-RasV12 and loss of p53. PLoS ONE 9(4), e95869 (2014). https://doi.org/10.1371/journal.pone.0095869
CAS PubMed PubMed Central Google Scholar
M. Cicek, R. Fukuyama, M.S. Cicek, S. Sizemore, D.R. Welch, N. Sizemore, G. Casey, BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter. Clin. Exp. Metastasis 26(3), 229–237 (2009). https://doi.org/10.1007/s10585-009-9235-1
CAS PubMed PubMed Central Google Scholar
J. Li, G. Li, Cell cycle regulator ING4 is a suppressor of melanoma angiogenesis that is regulated by the metastasis suppressor BRMS1. Cancer Res. 70(24), 10445–10453 (2010). https://doi.org/10.1158/0008-5472.CAN-10-3040
O.I. Kit, E.M. Frantsiyants, L.S. Kozlova, E.E. Rostorguev, I.V. Balyazin-Parfenov, Y.A. Pogorelova, [A plasminogen regulation system in brain tumors]. Zhurnal voprosy neirokhirurgii imeni. N N Burdenko 81(2), 22–27 (2017). https://doi.org/10.17116/neiro201781222-27
G. Klironomos, V. Bravou, D.J. Papachristou, G. Gatzounis, J. Varakis, E. Parassi, M. Repanti, H. Papadaki, Loss of inhibitor of growth (ING-4) is implicated in the pathogenesis and progression of human astrocytomas. Brain Pathol. 20(2), 490–497 (2010). https://doi.org/10.1111/j.1750-3639.2009.00325.x
E.G. Van Meir, T. Kikuchi, M. Tada, H. Li, A.C. Diserens, B.E. Wojcik, H.J. Huang, T. Friedmann, N. de Tribolet, W.K. Cavenee, Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res. 54(3), 649–652 (1994)
G.R. Sareddy, K. Geeviman, C. Ramulu, P.P. Babu, The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-kappaB pathway. J. Neurooncol. 106(1), 99–109 (2012). https://doi.org/10.1007/s11060-011-0662-x
G.R. Sareddy, M. Panigrahi, S. Challa, A. Mahadevan, P.P. Babu, Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas. Neurochem. Int. 55(5), 307–317 (2009). https://doi.org/10.1016/j.neuint.2009.03.016
D. Babu, A. Mudiraj, N. Yadav, B.V.K.C. Y, M. Panigrahi, P. Prakash Babu, Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition. Cell. Oncol. (Dordr) (2021). https://doi.org/10.1007/s13402-021-00609-w
F. Varghese, A.B. Bukhari, R. Malhotra, A. De, IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS ONE 9(5), e96801 (2014). https://doi.org/10.1371/journal.pone.0096801
CAS PubMed PubMed Central Google Scholar
L. Du, C.S. Lyle, T.B. Obey, W.A. Gaarde, J.A. Muir, B.L. Bennett, T.C. Chambers, Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent. J. Biol. Chem. 279(12), 11957–11966 (2004). https://doi.org/10.1074/jbc.M304935200
D.S. Chandrashekar, B. Bashel, S.A.H. Balasubramanya, C.J. Creighton, I. Ponce-Rodriguez, B. Chakravarthi, S. Varambally, UALCAN: A Portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19(8), 649–658 (2017). https://doi.org/10.1016/j.neo.2017.05.002
CAS PubMed PubMed Central Google Scholar
X. Liu, E. Ehmed, B. Li, J. Dou, X. Qiao, W. Jiang, X. Yang, S. Qiao, Y. Wu, Breast cancer metastasis suppressor 1 modulates SIRT1-dependent p53 deacetylation through interacting with DBC1. Am. J. Cancer Res. 6(6), 1441–1449 (2016)
留言 (0)